Pfizer has encountered many setbacks in its quest to launch a medicine that could rival Wegovy and Zepbound. One of its ...

One man's trash may be another man's treasure, but dumpster diving when investing carries risks. You have to wade through a ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

PARIS – Amid the luxury slowdown, Hermès International showed continued strength with sales in the first quarter up 7 percent ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and ...

Pfizer on Monday said it has discontinued development of experimental weight-loss pill danuglipron after a trial patient experienced potential drug-induced liver injury which resolved after the ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Study results in a rare form of obesity could help the company expand use of Imcivree, which is approved for two genetically ...

U.S. President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program. The Centers for Medicare and ...

Joe Biden had proposed a rule in late November after Trump won re-election that would have extended coverage of drugs like Zepbound and Wegovy, however, the former US President's proposal was ...